Retrospective Analysis of Risk Factors for Cefoperazone/Sulbactam-Induced Thrombocytopenia in Adult Chinese Patients: A Six-Year Real-World Study
Article in Infection and Drug Resistance (September 2024)
The most recent citing publications are shown below. View all 3 publications that cite this research output on Dimensions.
Development and internal validation of a model for predicting cefoperazone/sulbactam-associated coagulation disorders in Chinese inpatients
Article in BMC Pharmacology and Toxicology (July 2024)
Cefoperazone targets D-alanyl-D-alanine carboxypeptidase (DAC) to control Morganella morganii-mediated infection: a subtractive genomic and molecular dynamics approach
Article in Journal of Biomolecular Structure and Dynamics (July 2023)